Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

SAN DIEGO, CA—Left bundle branch area pacing (LBBAP) is associated with better outcomes than biventricular (BiV) pacing among patients with an LVEF of 50% or less requiring cardiac resynchronization ...

Abbott Laboratories, Inc. ABT has completed the world's first-in-human leadless left bundle branch area pacing (LBBAP) procedures. The landmark procedures were part of the prospective Leadless CSP ...

BERLIN, Germany—Conduction-system pacing (CSP), including His-bundle and left bundle branch area pacing (LBBAP), has emerged as an alternative to biventricular pacing for patients treated with cardiac ...

Abbott (ABT)'s investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that Professor Pascal Defaye, Head of Rhythmology ...

Two new studies outline new clinical applications for WiSE cardiac pacing device One application pairs WiSE with a leadless pacemaker to deliver leadless LBBAP/CSP The other involves using WiSE to ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating ...

Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker Enrollment has also ...